SCHEMBL7121348

SCHEMBL7121348

CN(CCO)C1CCCCCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
FAAH O00519 1/20 0.39
PHGDH O43175 1/20 0.39
MGLL Q99685 1/20 0.39
ADH1A P07327 3/20 0.38
ADH1C P00326 2/20 0.38
MAPT P10636 1/20 0.38
KDM4E B2RXH2 1/20 0.37
CYP2D6 P10635 2/20 0.36
CYP1A2 P05177 1/20 0.36
ALDH1A1 P00352 3/20 0.35
HTT P42858 1/20 0.35
FDPS P14324 1/20 0.34
ABCB11 O95342 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
AR P10275 1/20 0.34
SLC6A2 P23975 1/20 0.34
PDE4A P27815 1/20 0.34
SLC6A4 P31645 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9949828 1.00 HRH4 (0.42) HRH4HRH3FAAHPHGDHMGLL
SCHEMBL803958 1.00 HRH4 (0.42) HRH4HRH3FAAHPHGDHMGLL
Hydrochloric Acid SCHEMBL4346253 0.98 HRH4 (0.41) HRH4HRH3FAAHPHGDHMGLL
SCHEMBL7114265 0.98 HRH4 (0.39) HRH4HRH3FAAHPHGDHMGLL
SCHEMBL7114292 0.95
SCHEMBL7118919 0.87
SCHEMBL17743426 0.86 HRH4 (0.40) HRH4HRH3FAAHPHGDHMGLL
SCHEMBL1131900 0.86 HRH4 (0.40) HRH4HRH3FAAHPHGDHMGLL
Hydrochloric Acid SCHEMBL4341705 0.85
SCHEMBL17743439 0.85 HRH4 (0.39) HRH4HRH3FAAHPHGDHMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230286902-A1 LIPID NANOPARTICLE COMPOSITION Suzhou Abogen Biosciences Co., Ltd. (CN) 2023-09-14 US disclosed
US-20230286902-A1 LIPID NANOPARTICLE COMPOSITION Suzhou Abogen Biosciences Co., Ltd. (CN) 2023-09-14 US disclosed
CN-106943848-B Carbon dioxide capture system and method of operating a carbon dioxide capture system 株式会社东芝 2021-04-13 CN disclosed
US-10864478-B2 Carbon dioxide capture system and a method of operating a carbon dioxide capture system KABUSHIKI KAISHA TOSHIBA (JP) 2020-12-15 US disclosed
EP-2889073-B1 ACID GAS REMOVAL METHOD TOSHIBA KK (JP) 2020-09-02 EP disclosed
EP-3020464-B1 ACIDIC GAS ABSORBING AGENT, METHOD FOR REMOVING ACIDIC GAS AND APPARATUS FOR REMOVING ACIDIC GAS TOSHIBA KK (JP) 2019-10-02 EP disclosed
EP-2705894-B1 Acid gas absorbent, acid gas removal method and acid gas removal device TOSHIBA KK (JP) 2018-05-23 EP disclosed
US-20170165603-A1 CARBON DIOXIDE CAPTURE SYSTEM AND A METHOD OF OPERATING A CARBON DIOXIDE CAPTURE SYSTEM KABUSHIKI KAISHA TOSHIBA (JP) 2017-06-15 US disclosed
EP-2468385-B1 Acid gas absorbent, acid gas removal method and acid gas removal device TOSHIBA KK (JP) 2016-11-02 EP disclosed
US-9446346-B2 Acidic gas absorbing agent, method for removing acidic gas and apparatus for removing acidic gas KABUSHIKI KAISHA TOSHIBA (JP) 2016-09-20 US disclosed
EP-2913092-A1 Carbon dioxide recovery apparatus and carbon dioxide recovery method KABUSHIKI KAISHA TOSHIBA (JP) 2015-09-02 EP disclosed
EP-2889073-A1 Acid gas removal apparatus and acid gas removal method Kabushiki Kaisha Toshiba (JP) 2015-07-01 EP disclosed
US-20150174530-A1 ACID GAS REMOVAL APPARATUS AND ACID GAS REMOVAL METHOD KABUSHIKI KAISHA TOSHIBA (JP) 2015-06-25 US disclosed
EP-2705894-A1 Acid gas absorbent, acid gas removal method and acid gas removal device Kabushiki Kaisha Toshiba (JP) 2014-03-12 EP disclosed
US-20120161071-A1 ACID GAS ABSORBENT, ACID GAS REMOVAL METHOD, AND ACID GAS REMOVAL DEVICE KABUSHIKI KAISHA TOSHIBA (JP) 2012-06-28 US disclosed
EP-2468385-A2 Acid gas absorbent, acid gas removal method and acid gas removal device Kabushiki Kaisha Toshiba (JP) 2012-06-27 EP disclosed
US-20030207865-A1 Substituted 2-arylimino heterocycles and compositions containing them for use as progesterone receptor binding agents DIXON BRIAN R (US) 2003-11-06 US disclosed
US-6353006-B1 TREATMENT OF BONE DISORDERS, OSTEOPOROSIS AND HEALING AGENT BAYER CORPORATION 2002-03-05 US disclosed
EP-1144396-A2 SUBSTITUTED 2-ARYLIMINO HETEROCYCLES AND COMPOSITIONS CONTAINING THEM, FOR USE AS PROGESTERONE RECEPTOR BINDING AGENTS Bayer Corporation (US) 2001-10-17 EP disclosed
WO-2000042031-A2 SUBSTITUTED 2-ARYLIMINO HETEROCYCLES AND COMPOSITIONS CONTAINING THEM, FOR USE AS PROGESTERONE RECEPTOR BINDING AGENTS BAYER CORPORATION (US) 2000-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286902-A1 LIPID NANOPARTICLE COMPOSITION CETP, NPC1, LCAT HRH4 4638/4885HRH3 3817/4885FAAH 2063/4885
US-20030207865-A1 Substituted 2-arylimino heterocycles and compositions containing them for use as progesterone receptor binding agents PGR, PGRMC2, PGRMC1 HRH4 1543/4885HRH3 2155/4885FAAH 3677/4885
US-20120161071-A1 ACID GAS ABSORBENT, ACID GAS REMOVAL METHOD, AND ACID GAS REMOVAL DEVICE ALKBH1, ALKBH3, ALKBH2 HRH4 17/4885HRH3 12/4885FAAH 104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.